SCN9A rs6746030 多态性与症状性不可逆牙髓炎下牙槽神经阻滞失败的相关性
本研究为前瞻性临床遗传关联研究,纳入320例下颌磨牙症状性不可逆牙髓炎患者,均接受标准化下牙槽神经阻滞(2%利多卡因+1:80000肾上腺素)。结果199例失败、121例成功;AA基因型患者麻醉成功几率显著降低(OR=0.22;95%CI:0.049-0.993),GA基因型、年龄、性别无显著关联。
要点
- SCN9A rs6746030 AA基因型与下牙槽神经阻滞失败风险升高相关。
- 失败组Hardy-Weinberg平衡偏离提示遗传因素可能影响麻醉效果。
- 模型预测能力有限(AUC=0.53),基因型单独预测价值不高。
核心结论
- SCN9A rs6746030 AA基因型与下颌磨牙症状性不可逆牙髓炎患者下牙槽神经阻滞失败几率升高相关。
研究设计与样本
- 前瞻性临床遗传关联研究,纳入320例下颌磨牙症状性不可逆牙髓炎患者。
- 所有患者接受标准化下牙槽神经阻滞,使用2%利多卡因与1:80000肾上腺素。
- 采集颊拭子样本,采用TaqMan SNP法对rs6746030进行基因分型。
主要发现
- 320例中199例麻醉失败,121例成功。
- 失败组Hardy-Weinberg平衡检验显著偏离(p < 0.05),成功组无偏离(p = 0.99)。
- AA基因型患者麻醉成功几率显著降低(OR = 0.22;95% CI:0.049-0.993)。
- GA基因型、年龄、性别与麻醉成功无显著关联。
- 模型预测能力有限,AUC为0.53。
关键数值与推荐
- 麻醉成功定义为备洞/器械操作时Heft-Parker视觉模拟量表(HP-VAS)评分低于54 mm,54 mm及以上为失败。
临床怎么用
- 对下颌磨牙症状性不可逆牙髓炎患者,可考虑SCN9A rs6746030基因型检测以评估下牙槽神经阻滞失败风险。
- AA基因型患者可能需要辅助麻醉策略,但模型预测能力有限,不能仅凭基因型决策。
局限性
- 模型预测能力有限(AUC=0.53),基因型单独预测价值不高。
- 未报告其他潜在混杂因素的控制情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study evaluated whether the SCN9A rs6746030 (G>A; R1150W) polymorphism is associated with the clinical success or failure of pulpal anaesthesia following an inferior alveolar nerve block (IANB). METHODS: In this prospective clinical genetic association study, 320 patients with symptomatic irreversible pulpitis in mandibular molars were recruited. Each patient received a standardized IANB with 2% lidocaine and 1:80000 epinephrine. Anaesthesia was considered successful if the Heft-Parker Visual Analogue Scale (HP-VAS) score was below 54 mm during access cavity preparation/instrumentation; scores of 54 mm or higher were classified as failures. Buccal swab samples were collected for genotyping of rs6746030 using a TaqMan SNP assay. Genotype distributions were compared between the success and failure groups. Statistical analysis included Hardy-Weinberg equilibrium testing, chi-square comparisons, and binary logistic regression with genotype, age and gender as predictors. RESULTS: Out of 320 patients analysed, 199 experienced failed anaesthesia, while 121 achieved successful outcomes. A significant deviation from Hardy-Weinberg equilibrium was found in the failed anaesthesia group (p < 0.05), suggesting potential genetic influence, while the successful group showed no deviation (p = 0.99). Logistic regression revealed that patients with the AA genotype had significantly lower odds of successful anaesthesia (OR = 0.22; 95% CI: 0.049-0.993). No significant associations were observed for the GA genotype, age, or gender. The model's predictive ability was limited, with an AUC of 0.53. CONCLUSION: The rs6746030 polymorphism of SCN9A in its AA form is associated with a higher likelihood of IANB failure in mandibular molars with symptomatic irreversible pulpitis.
引用
- Aggarwal V, Gupta A, Singla M, et al. Association of the SCN9A rs6746030 (R1150W) Polymorphism on Inferior Alveolar Nerve Block Failure in Symptomatic Irreversible Pulpitis. Int Endod J. 2026. PMID: 42495805. doi:10.1111/iej.70236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。